COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - FRA:CBHD - DK0060448595 - Common Stock
80.8 EUR
-1.16 (-1.42%)
Taking everything into account, CBHD scores 5 out of 10 in our fundamental rating. CBHD was compared to 60 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are quite some concerns on its financial health. CBHD is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
CBHD had a positive operating cash flow in the past year.
CBHD had positive earnings in each of the past 5 years.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.51%, CBHD belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
The Return On Equity of CBHD (24.78%) is better than 93.33% of its industry peers.
CBHD has a better Return On Invested Capital (15.96%) than 96.67% of its industry peers.
CBHD had an Average Return On Invested Capital over the past 3 years of 16.81%. This is significantly above the industry average of 9.00%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROIC | 15.96% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
CBHD's Profit Margin of 14.62% is amongst the best of the industry. CBHD outperforms 85.00% of its industry peers.
CBHD's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 26.99%, CBHD belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
CBHD's Operating Margin has declined in the last couple of years.
CBHD has a better Gross Margin (67.55%) than 76.67% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
CBHD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CBHD has more shares outstanding
The number of shares outstanding for CBHD has been increased compared to 5 years ago.
The debt/assets ratio for CBHD is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.05 indicates that CBHD is not in any danger for bankruptcy at the moment.
CBHD's Altman-Z score of 4.05 is fine compared to the rest of the industry. CBHD outperforms 68.33% of its industry peers.
The Debt to FCF ratio of CBHD is 4.89, which is a neutral value as it means it would take CBHD, 4.89 years of fcf income to pay off all of its debts.
CBHD's Debt to FCF ratio of 4.89 is in line compared to the rest of the industry. CBHD outperforms 60.00% of its industry peers.
CBHD has a Debt/Equity ratio of 1.05. This is a high value indicating a heavy dependency on external financing.
CBHD's Debt to Equity ratio of 1.05 is on the low side compared to the rest of the industry. CBHD is outperformed by 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 4.05 |
ROIC/WACC2.63
WACC6.06%
2.3 Liquidity
CBHD has a Current Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a worse Current ratio (1.00) than 76.67% of its industry peers.
A Quick Ratio of 0.64 indicates that CBHD may have some problems paying its short term obligations.
The Quick ratio of CBHD (0.64) is worse than 78.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -13.94% in the last year.
CBHD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.72% yearly.
The Revenue has been growing slightly by 5.95% in the past year.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.54% yearly.
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.04% on average per year.
Based on estimates for the next years, CBHD will show a small growth in Revenue. The Revenue will grow by 6.65% on average per year.
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 31.69, the valuation of CBHD can be described as expensive.
CBHD's Price/Earnings ratio is in line with the industry average.
CBHD is valuated rather expensively when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 23.07.
CBHD's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 32.68. CBHD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.69 | ||
| Fwd PE | 23.07 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as CBHD.
Based on the Price/Free Cash Flow ratio, CBHD is valued a bit cheaper than 71.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.63 | ||
| EV/EBITDA | 17.15 |
4.3 Compensation for Growth
CBHD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)11.65
EPS Next 2Y7.9%
EPS Next 3Y9%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.73%.
Compared to an average industry Dividend Yield of 2.13, CBHD pays a better dividend. On top of this CBHD pays more dividend than 98.33% of the companies listed in the same industry.
CBHD's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.73% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
121.67% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP121.67%
EPS Next 2Y7.9%
EPS Next 3Y9%
FRA:CBHD (11/7/2025, 7:00:00 PM)
80.8
-1.16 (-1.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap16.98B
Revenue(TTM)27.87B
Net Income(TTM)4.08B
Analysts67.69
Price Target92.76 (14.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.73% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP121.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-18.87%
Min EPS beat(2)-22.36%
Max EPS beat(2)-15.38%
EPS beat(4)0
Avg EPS beat(4)-13.35%
Min EPS beat(4)-22.36%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-10.21%
EPS beat(12)0
Avg EPS beat(12)-8.91%
EPS beat(16)1
Avg EPS beat(16)-7.89%
Revenue beat(2)0
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-2.12%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.52%
Revenue beat(12)1
Avg Revenue beat(12)-1.36%
Revenue beat(16)4
Avg Revenue beat(16)-0.78%
PT rev (1m)-2.1%
PT rev (3m)-8.33%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.69 | ||
| Fwd PE | 23.07 | ||
| P/S | 4.55 | ||
| P/FCF | 25.63 | ||
| P/OCF | 19.73 | ||
| P/B | 7.71 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.15 |
EPS(TTM)2.55
EY3.16%
EPS(NY)3.5
Fwd EY4.33%
FCF(TTM)3.15
FCFY3.9%
OCF(TTM)4.1
OCFY5.07%
SpS17.75
BVpS10.48
TBVpS-8.58
PEG (NY)N/A
PEG (5Y)11.65
Graham Number24.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.51% | ||
| ROE | 24.78% | ||
| ROCE | 20.15% | ||
| ROIC | 15.96% | ||
| ROICexc | 16.27% | ||
| ROICexgc | 89.1% | ||
| OM | 26.99% | ||
| PM (TTM) | 14.62% | ||
| GM | 67.55% | ||
| FCFM | 17.76% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexgc growth 3Y7.74%
ROICexgc growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.05 | ||
| Debt/FCF | 4.89 | ||
| Debt/EBITDA | 1.95 | ||
| Cap/Depr | 109.63% | ||
| Cap/Sales | 5.31% | ||
| Interest Coverage | 7.46 | ||
| Cash Conversion | 72.46% | ||
| Profit Quality | 121.42% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 0.64 | ||
| Altman-Z | 4.05 |
F-Score6
WACC6.06%
ROIC/WACC2.63
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-30.39%
EPS Next Y-2.42%
EPS Next 2Y7.9%
EPS Next 3Y9%
EPS Next 5Y10.04%
Revenue 1Y (TTM)5.95%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%1.06%
Revenue Next Year3.9%
Revenue Next 2Y4.92%
Revenue Next 3Y5.76%
Revenue Next 5Y6.65%
EBIT growth 1Y4.5%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year22.79%
EBIT Next 3Y12.78%
EBIT Next 5Y11.59%
FCF growth 1Y53.38%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y43.32%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 3 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Overvalued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 8 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 3 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to decline by -2.42% in the next year.